Sponsor:
UCLA
Code:
NCT06143631
Conditions
Leiomyoma, Uterine
Leiomyoma
Fibroid
Fibroid Uterus
Eligibility Criteria
Sex: Female
Age: 21 - 53
Healthy Volunteers: Accepted
Interventions
Letrozole 2.5mg
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-25. This information was provided to ClinicalTrials.gov by University of California, San Francisco on 2026-05-20.